Clinical Pharmacology Strategy

Real World Evidence Marches Forward in Drug Development

Ulrich Neumann

The end of 2018 ushered in a flurry of new regulatory guidance and sponsor enthusiasm on real-world evidence (RWE) and its adoption in the drug development process. While the collection of real-world data (RWD) and use of RWE is not new, they are now poised to have a profound impact on our industry.  Today, it […]

Read More
Topics: Clinical Pharmacology Strategy

Benefits of Apocalyptic Clinical Pharmacology During Regulatory Review

Graham Scott

When developing a drug, pharmaceutical companies need to answer many questions to successfully undergo regulatory review and bring the drug to market. Apocalyptic clinical pharmacology is a framework that drug developers can use to uncover essential relationships between the drug dose and response or outcome. In other recent blog posts, I have covered what the […]

Read More
Topics: Clinical Pharmacology Strategy, PBPK Modeling & Simulation
Learn More LinkedIn Twitter Facebook Email